Miyakogusa Predicted Gene

Lj0g3v0256909.1
Show Alignment: 

BLASTP 2.2.25 [Feb-01-2011]


Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer, 
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), 
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs",  Nucleic Acids Res. 25:3389-3402.

Reference for compositional score matrix adjustment: Altschul, Stephen F., 
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.

Query= Lj0g3v0256909.1 Non Characterized Hit- tr|I1LS21|I1LS21_SOYBN
Uncharacterized protein OS=Glycine max PE=4
SV=1,76.13,0,LUMAZINE_BIND,Lumazine-binding domain; seg,NULL; no
description,ATPase, F1/A1 complex, alpha subunit,CUFF.16891.1
         (276 letters)

Database: Medicago_aa4.0v1 
           62,319 sequences; 21,947,249 total letters

Searching..................................................done



                                                                 Score    E
Sequences producing significant alignments:                      (bits) Value

Medtr1g066930.1 | riboflavin synthase alpha chain | HC | chr1:28...   352   2e-97
Medtr0004s0220.1 | riboflavin synthase alpha chain | HC | scaffo...   348   4e-96
Medtr4g063470.1 | riboflavin synthase alpha chain | HC | chr4:23...    98   1e-20

>Medtr1g066930.1 | riboflavin synthase alpha chain | HC |
           chr1:28769066-28767710 | 20130731
          Length = 275

 Score =  352 bits (903), Expect = 2e-97,   Method: Compositional matrix adjust.
 Identities = 179/237 (75%), Positives = 204/237 (86%), Gaps = 3/237 (1%)

Query: 38  KPSPLRFFLPLTPQNPHHHRRRSAV-VTNMFTGLVEELGTVKQLGMASHGGFDLNVEAKT 96
           KPSPLR FL  T + P   R  + + +  +FTGLVEE+GTVK+LG + +GGFDL + AKT
Sbjct: 29  KPSPLRIFLQST-RKPITLRTNAYIPIQCLFTGLVEEIGTVKKLGESPNGGFDLQLNAKT 87

Query: 97  VLEGVILGDSIAVNGTCLTVTEFDLEGSNFTVGLSPETLRKTSLEELEPGSVVNLERALL 156
           VL+GV LGDSIAVNGTCLTVTEFD   S+FTVG++PETLRKTSL ELEPGS VNLERAL 
Sbjct: 88  VLDGVSLGDSIAVNGTCLTVTEFDQIASDFTVGVAPETLRKTSLLELEPGSPVNLERALT 147

Query: 157 PTTRMGGHFVQGHVDGTGVIVSMDAEGDSLWVKVKAE-KEVLKYIVPKGFIAVDGTSLTV 215
           P +RMGGHFVQGHVDGTG IVSM  EGDSLWVK++ E KE+LKYIVPKGFIAVDGTSLTV
Sbjct: 148 PLSRMGGHFVQGHVDGTGEIVSMIPEGDSLWVKIRVEKKELLKYIVPKGFIAVDGTSLTV 207

Query: 216 VDVFDDEGCFNFMLVAYTQQKVVIPLKKVGRKVNLEVDILGKYVERLLSSGFVQSIA 272
           VDVFDDEGCFNFMLVAYTQ K+V+P+KK+G+KVNLEVD+LGK+VERLLSSGFV SIA
Sbjct: 208 VDVFDDEGCFNFMLVAYTQNKIVVPMKKIGQKVNLEVDVLGKHVERLLSSGFVPSIA 264


>Medtr0004s0220.1 | riboflavin synthase alpha chain | HC |
           scaffold0004:89120-90105 | 20130731
          Length = 257

 Score =  348 bits (892), Expect = 4e-96,   Method: Compositional matrix adjust.
 Identities = 181/244 (74%), Positives = 202/244 (82%), Gaps = 9/244 (3%)

Query: 24  HHSTFT-NLRFNPIAKPSPLRFFLPLTPQNPHHHRRRSAVVTNMFTGLVEELGTVKQLGM 82
           H+S  T +LRF    KPSPLRFFLP +        R    +  +FTGLVEE+GTVK+LG 
Sbjct: 16  HNSQITPHLRF----KPSPLRFFLPSSSSTRKSIHRP---IQCLFTGLVEEMGTVKKLGA 68

Query: 83  ASHGGFDLNVEAKTVLEGVILGDSIAVNGTCLTVTEFDLEGSNFTVGLSPETLRKTSLEE 142
           AS+GGFDL VEAKTVL+GV LGDSIAVNGTCLTVTEFD + S+FTVGL+PETLRKTSL E
Sbjct: 69  ASNGGFDLKVEAKTVLDGVSLGDSIAVNGTCLTVTEFDTKASDFTVGLAPETLRKTSLIE 128

Query: 143 LEPGSVVNLERALLPTTRMGGHFVQGHVDGTGVIVSMDAEGDSLWVKVKAEK-EVLKYIV 201
           LEPGS VNLER++ P TRMGGHFVQGHVDGTG IVSM  E DSLW+KV+  K ++LKYIV
Sbjct: 129 LEPGSPVNLERSVTPVTRMGGHFVQGHVDGTGEIVSMVPERDSLWIKVRVNKVDLLKYIV 188

Query: 202 PKGFIAVDGTSLTVVDVFDDEGCFNFMLVAYTQQKVVIPLKKVGRKVNLEVDILGKYVER 261
           PKGFIAVDGTSLTVVDVFDDE CFNFMLVAYTQ K+VIPLK VG+KVNLEVDILGKYVER
Sbjct: 189 PKGFIAVDGTSLTVVDVFDDEACFNFMLVAYTQSKIVIPLKNVGQKVNLEVDILGKYVER 248

Query: 262 LLSS 265
           LL +
Sbjct: 249 LLRT 252


>Medtr4g063470.1 | riboflavin synthase alpha chain | HC |
           chr4:23534842-23534594 | 20130731
          Length = 82

 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 48/70 (68%), Positives = 58/70 (82%)

Query: 74  LGTVKQLGMASHGGFDLNVEAKTVLEGVILGDSIAVNGTCLTVTEFDLEGSNFTVGLSPE 133
           +GTVKQLG+A+ GGFDL VEAKTVL+ + L DSI VN TCLTVTEFD + S+FTVGL+ E
Sbjct: 1   MGTVKQLGVATDGGFDLKVEAKTVLDDISLRDSIVVNCTCLTVTEFDPKASDFTVGLAQE 60

Query: 134 TLRKTSLEEL 143
           TLRKT+ E+ 
Sbjct: 61  TLRKTAHEDF 70